Mezinex Antitusif

Mezinex Antitusif

triprolidine + pseudoephedrine + dextromethorphan

Manufacturer:

Ifars
Full Prescribing Info
Contents
Triprolidine HCl, pseudoephedrine HCl, dextromethorphan HBr.
Description
Each 5 mL (1 teaspoonful) syrup contains: Triprolidine HCl 1.25 mg, pseudoephedrine HCl 30 mg, dextromethorphan HBr 10 mg.
Indications/Uses
Relieves cold and dry cough.
Dosage/Direction for Use
Adults and children >12 years 5 mL (1 tsp) 3 times daily. Children 6-12 years 2.5 mL (1/2 tsp) 3 times daily.
Contraindications
Patients with heart problems and diabetes mellitus. Hypersensitivity to Triprolidine HCI, Pseudoephedrine HCI, Dextromethorphan HBr, and other components in this drug.
Special Precautions
Patients who are sensitive to other sympathomimetic drugs (eg Ephedrine, Phenylpropanolamine, Phenylephrine), people with severe high blood pressure, and who are receiving anti-depressant drug therapy of the type of monoamine oxidase inhibitor (MAOI). If within 3 days the symptoms do not decrease, immediately contact the Health Service Unit.
Stop using this medicine if you have trouble sleeping, heart palpitations, and dizziness.
Cough accompanied by fever, redness of the skin, or persistent headache.
Continuous and long-term cough (especially in people with asthma, emphysema) and cough with excessive phlegm.
Patients with impaired liver, kidney, glaucoma, prostate hypertrophy, epilepsy, hyperthyroidism and urinary retention, heart problems, diabetes mellitus, arrhythmias, asthma, bronchitis and phaechromocytoma.
Debil and hypoxia (lack of oxygen). May cause respiratory depression and central nervous system on large doses or in patients with impaired respiratory function (eg asthma, emphysema).
Avoid concurrent use with other cold and cough medicines, anthihistamines, appetite suppressant drugs, drugs containing amphetamines, and drugs that suppress the CNS.
Should not exceed the recommended dosage. Children <6 years, pregnant and lactating, unless under doctor's instructions. Overweight or elderly.
Adverse Reactions
Drowsiness, sedation, nervousness, insomnia, dizziness, dry mouth, nose or throat, indigestion (nausea, vomiting), attention and coordination disorders, hallucinations (especially in children), psychomotor disorders, tachycardia, arrhythmia, palpitations, difficulty urination, and allergies (redness of the skin, sometimes accompanied by difficulty breathing, swelling of the face or throat). Serotonin syndrome (very rare) feeling confused, tired, sweating, shaking, sudden muscle contractions, or increased blood pressure.
Drug Interactions
Concomitant use with sympathomimetic drugs such as decongestants, tricyclic antidepressants, appetite suppressants, and psychostimulants such as amphetamines, or with monoamine oxidase inhibitors that interfere with catabolism of sympathomimetic amines, can cause an increase in blood pressure. Bretylium, Bethanidine, Guanethidine Debrisoquine, Methyldopa, and beta/alpha adrenergic blocking agents. Furazolidone antibacterial may cause monoamine oxidase inhibitor depending on the dose. Furazolidone. Alcohol and other sedatives those work on the central nervous system.
MIMS Class
Cough & Cold Preparations
ATC Classification
R05DA20 - combinations ; Belongs to the class of opium alkaloids and derivatives. Used as cough suppressant.
Presentation/Packing
Form
Mezinex Antitusif syr
Packing/Price
60 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in